Abstract
After the detonation of an improvised nuclear device, several key actions will be necessary to save the greatest number of lives possible. Among these tasks, the identification of patients with impending acute radiation sickness is a critical problem that so far has lacked a clear solution in national planning. We present one possible solution: the formation of a public-private partnership to augment the capacity to identify those at risk for acute radiation sickness.
After the detonation of an improvised nuclear device, several actions will be necessary to save the greatest number of lives possible. Among these tasks, the identification of patients with impending acute radiation sickness is a critical problem. The authors propose the formation of a public-private partnership with clinical lab firms to identify those at risk for acute radiation sickness.
Get full access to this article
View all access options for this article.
